Craniosynostosis: from a clinical description to an understanding of bone formation of the skull.
The genetic studies of syndromic craniosynostoses lead to the characterisation of genes that regulate the correct development of the bones of the skull. From these studies, it appears that FGF/FGFR signalling has a crucial role in this problem. Numerous mutations affecting the genes coding for FGFR1, 2 or 3 are responsible for these syndromes. It is interesting to note that some identical mutations produced various different phenotypes, suggesting that other genes modulate the phenotypic expressivity. The other involved genes in these syndromes code for such proteins as Msx2 or Twist that interact in the cellular pathways responsible for FGF action. From these genetic studies, it is now important to establish the role of these proteins during the development of the skull. Msx2 plays a repressive role in osteogenesis, whereas FGFRs act as promoting proteins. In the near future, it will be very important to improve our understanding of these phenomena in order to test specific treatments to prevent the development of such syndromes.
Lajeunie
E
E
Service de Neurochirurgie Pédiatrique, Hôpital Necker-Enfants Malades, Paris, France.
Catala
M
M
Renier
D
D
D000818:Animals; D003398:Craniosynostoses / Q000235:genetics* / Q000473:pathology*; D004285:Dogs; D005346:Fibroblast Growth Factors / Q000235:genetics; D006801:Humans; D009154:Mutation; D010012:Osteogenesis / Q000235:genetics*; D017468:Receptors, Fibroblast Growth Factor / Q000235:genetics*; D013577:Syndrome; D014157:Transcription Factors / Q000235:genetics
D017468:Receptors, Fibroblast Growth Factor; D014157:Transcription Factors; D005346:Fibroblast Growth Factors